Response to anti-VEGF injections for diabetic macular edema among patients on chronic exogenous insulin therapy.
PURPOSE Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients worldwide. This study assessed whether there was a difference in functional and anatomic responsiveness to anti-VEGF therapy for DME among patients on chronic exogenous insulin therapy. METHODS This was a single-center retrosp...